Safety and Effectiveness of Low-Dose Cytomegalovirus Valganciclovir Prophylaxis in CMV Seropositive Lung Transplant Recipients

Autor: Lehikoinen, R.A., Syrjälä, S., Heliövaara, E., Tikkanen, J., Lemström, K.
Zdroj: In Journal of Heart and Lung Transplantation April 2022 41(4) Supplement:S486-S486
Databáze: ScienceDirect